SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-121017
Filing Date
2021-09-30
Accepted
2021-09-30 08:52:20
Documents
16
Period of Report
2021-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2128746d1_8k.htm   iXBRL 8-K 32757
2 EXHIBIT 1.1 tm2128746d1_ex1-1.htm EX-1.1 242203
3 EXHIBIT 5.1 tm2128746d1_ex5-1.htm EX-5.1 13988
4 EXHIBIT 23.2 tm2128746d1_ex23-2.htm EX-23.2 2761
8 GRAPHIC tm2128746d1_ex5-1img001.jpg GRAPHIC 5577
  Complete submission text file 0001104659-21-121017.txt   541802

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA elox-20210930.xsd EX-101.SCH 3198
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20210930_lab.xml EX-101.LAB 34594
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20210930_pre.xml EX-101.PRE 22719
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2128746d1_8k_htm.xml XML 3504
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 211293785
SIC: 8731 Services-Commercial Physical & Biological Research